Dose Optimization of Caffeine for HIE
Public ClinicalTrials.gov record NCT06448780. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Dose Optimization of Caffeine in Neonates With Hypoxic-Ischemic Encephalopathy
Study identification
- NCT ID
- NCT06448780
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Enrollment
- 16 participants
Conditions and interventions
Conditions
Interventions
- Caffeine citrate 20 mg/kg Drug
- Caffeine citrate 30 mg/kg Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 24 Hours
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 25, 2024
- Primary completion
- Nov 30, 2026
- Completion
- Oct 31, 2028
- Last update posted
- Apr 6, 2026
2024 – 2028
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of North Carolina at Chapel Hill Newborn Critical Care Center | Chapel Hill | North Carolina | 27599 | Recruiting |
| Novant Health New Hanover Regional Medical Center | Wilmington | North Carolina | 28401 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06448780, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06448780 live on ClinicalTrials.gov.